Skip to main content

Rawlings scholars exhibit wide-ranging research

About three dozen Cornell seniors presented their undergraduate research at the 17th annual Hunter R. Rawlings III Research Scholars Senior Expo on April 17.

Study reveals link between starch digestion gene, gut bacteria

A newly discovered relationship between genetic variation and the gut microbiome could help nutritionists personalize their recommendations.

Five inducted into Bouchet Graduate Honor Society

Five Cornell doctoral candidates have been inducted into the Cornell chapter of the Edward A. Bouchet Graduate Honor Society.

Students showcase their community engagement work

Cornell students shared their global experiences through posters April 15 at the 2019 Community Engagement Showcase.

Ceci, Zamudio elected to American Academy of Arts and Sciences

Two Cornell faculty members with expertise in psychology and evolutionary biology and have been elected to the American Academy of Arts and Sciences, the academy announced April 17.

Renowned psychologist, neuroscientist to deliver Doris Lecture

Avshalom Caspi ’83, Ph.D. ’86, will return to Cornell to deliver the Bronfenbrenner Center for Translational Research’s annual John Doris Memorial Lecture on April 25. Caspi will discuss the implications of charting mental disorders from childhood to midlife.

Online health searches in Africa reveal stigmas, needs

Researchers have collected and analyzed health-related internet search terms from all 54 countries in Africa, finding that searches such as “Does garlic cure AIDS?” can reveal pockets of disease prevalence, cultural stigmas and urgent needs for accurate health information.

Entrepreneur of the Year shows power of persistence

Dr. Leonard Schleifer ’73, the 2019 Cornell Entrepreneur of the Year, shared the successes and failures he experienced while growing his biotechnology company, Regeneron, during an April 11 conversation with Lance Collins, the Joseph Silbert Dean of Engineering.

Ketamine’s short-term relief of depression could be extended, researchers find

The temporary benefits of ketamine against depression might be extended if the new brain-cell connections it promotes could be preserved, according to a study by researchers at Weill Cornell Medicine.